Optavia
Overview, company details, product information, news, events, rankings and Rep listings for Optavia.
Optavia Current Status and History
OPTAVIA is the principal direct-selling brand of publicly traded Medifast, Inc., a Baltimore-based nutrition company whose history dates to 1980. Medifast gradually shifted its coach-based weight-loss business from the Take Shape for Life name to OPTAVIA beginning in the mid-2010s. The program combines portion-controlled foods, structured meal plans, educational materials, habit-building guidance and support from independent coaches.
The company's principal products are packaged foods known as OPTAVIA Fuelings, including shakes, bars, soups, oatmeal, pancakes, snacks and other portion-controlled meals. Clients generally combine Fuelings with home-prepared Lean & Green meals, consisting of lean protein and non-starchy vegetables. OPTAVIA has also expanded into essential amino-acid blends, hydration products and programs focused on weight maintenance and metabolic health.
OPTAVIA operates through a multilevel direct-selling structure. Independent Coaches earn client-support commissions on product orders and can receive additional bonuses and leadership compensation by sponsoring and developing other Coaches. The current integrated compensation plan includes client-acquisition incentives, team-building bonuses, rank advancement and organization-based commissions. OPTAVIA reduced certain client-support commission rates in September 2025 and introduced additional coach incentives in 2026 as it worked to rebuild its field organization.
Medifast generated $385.8 million in full-year 2025 revenue, down approximately 36% from the prior year, as demand weakened and the number of earning Coaches fell. Management has attributed part of the decline to increased competition from GLP-1 weight-loss medications and broader difficulty acquiring new clients. Nicholas Johnson became Medifast's chief executive officer in 2026, succeeding Dan Chard, who remained chairman.
Company timeline
- 2017 Medifast renames its Take Shape for Life business OPTAVIA on July 24.
- 2024 Medifast begins offering medically supported weight loss through a collaboration with LifeMD, combining OPTAVIA coaching with access to affiliated clinicians and medications such as GLP-1s.
- 2026 Medifast's board appoints Nicholas Johnson chief executive officer effective June 1, and Dan Chard remains chairman.
- 2026 Medifast rebrands OPTAVIA as Trilivy, a metabolic-health system, while independent coaches remain central to the model.
Executive Team
Nicholas Johnson, Chief Executive Officer, Medifast
Dan Chard, Chairman, Medifast
Executive Bios
Optavia News
Medifast Loses Top Zacks Rating as Analysts Turn Cautious on Unprofitable OPTAVIA Parent
BALTIMORE, Maryland - November 11, 2026 Medifast, the Baltimore-based company that sells its weight-management products through the OPTAVIA network of...
Medifast Q3 Revenue Falls 19.4% to $72 Million as Active Optavia/Trilivy Coaches Drop 48% to 10,200
BALTIMORE, Maryland - October 26, 2026 Medifast, Inc., the publicly traded parent of the coach-based nutrition business formerly marketed as Optavia and...
Optavia Parent Reports Second Quarter Revenue of 76.4 Million Dollars
BALTIMORE, Md. -- August 3, 2026 Medifast reported second-quarter 2026 revenue of 76.4 million dollars for its Optavia business, with revenue per active...
Optavia Parent Rebrands Lifestyle Brand as Trilivy Metabolic Health System
BALTIMORE, Md. -- July 17, 2026 Medifast said it is rebranding OPTAVIA, its lifestyle brand and wholly owned subsidiary, as Trilivy, describing the new...
Medifast Appoints Nicholas Johnson CEO Effective June 1 as Dan Chard Becomes Chairman
BALTIMORE, Md. -- May 26, 2026 Medifast said its board has appointed President Nicholas Johnson as chief executive officer effective June 1, 2026, completing...
Related companies and people
These people and companies appear in the public record around Optavia:
Sources
- PR Newswire — July 24, 2017 Medifast release announcing that Take Shape for Life has rebranded to OPTAVIA.
- Medifast IR — April 29, 2024 first-quarter release stating that, through the LifeMD collaboration, OPTAVIA customers have access to affiliated clinicians and medications such as GLP-1s.
- Medifast IR — May 26, 2026 release confirming Johnson's appointment as CEO effective June 1, 2026, with Chard remaining chairman.
- Medifast IR — July 17, 2026 release announcing the launch of Trilivy as the successor to the OPTAVIA brand and continuing the independent-coach model.
OptaviaRep Listings
Npros Business Verification
Since 1999, Npros has researched MLM, network marketing, direct sales and home party companies, documenting company histories, executives and industry changes. Profiles draw on available corporate records, regulatory actions, court filings, company disclosures and historical archives. The verified date identifies when Npros last reviewed the public record and updated the profile's status and facts.
Historical information is preserved for reference and may describe products, compensation plans or business practices that have since changed. Verification reflects a review of available information; it is not an endorsement, financial audit or assurance of earnings. Advertising and paid listings are separate from company research.